Evolugate Improves DNA-Plasmid Production, Ready To Impact COVID-19 Vaccines Manufacturing Throughput
UF startup Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing.
Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture COVID-19 Vaccines
The COVID-19 epidemic has left the world devastated, with over 350,000 dead and the global economy in shambles in just 5 months.... Read More
